• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

ERYtech Pharma

edit

ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

Milestones

edit

• 
  ERYtech Pharma received $903k (€750k) in Series A funding. (11/3/05)
  Posted 9/5/10 at 9:21pm via erytech.com
• 
  ERYtech Pharma received $15.8M (€12M) in Venture Round funding. (12/22/06)
  Posted 4/22/10 at 4:13am via erytech.com

Videos

Screenshots

edit

Above: ERYtech Pharma
Uploaded: 4/22/10

Sources

1. ERYtech Pharma achieves its fund raising and starts a Phase II clinical trial (erytech.com) [edit]
2. ERYtech Pharma raises €12 million to boost its development. (erytech.com) [edit]